Village Integrated Eye Workers Trial
Village Integrated Eye Workers Trial
批准号:
9335362
负责人:
THOMAS M LIETMAN
金额:
$17.85万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2019-08-31
关键词:
AddressAfricaAnti-Bacterial AgentsAntibiotic ProphylaxisAntibioticsAntifungal AgentsAreaAsiaBhutanBlindnessCaliforniaCensusesChloramphenicolCicatrixClinicClinicalClinical TrialsCollaborationsCommunitiesCommunity HealthCommunity OutreachCorneaCorneal AbrasionCorneal DiseasesCorneal OpacityCorneal UlcerCost AnalysisDeveloping CountriesDiagnosisEpidemiologyEthicsEyeEye diseasesHarvestHealth PromotionHealth StatusHealth care facilityHealthcareHospitalsHourIncidenceIncidence StudyIndiaInfectionInterventionKeratitisLeprosyLogisticsMasksMeasuresMethodsMonitorMorbidity - disease rateMyanmarMycosesNepalOintmentsOnchocerciasisOutcomePatientsPersonsPoliciesPopulationPreventionPrevention programPreventive InterventionProphylactic treatmentProspective cohort studyRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRecording of previous eventsResearchResearch InfrastructureResolutionRuralRural CommunitySan FranciscoSeasonsServicesSurveysTrachomaTrainingTreatment EfficacyUlcerUnited StatesUniversitiesVillage Health WorkersVisionVisitVisualVisual impairmentWagesantimicrobialblindcostcost effectivecost effectivenesseffective interventionevidence baseimprovedmicrobialpopulation basedpreventprimary outcomeprogramspublic health relevancerandomized trialscale upstandard of caretopical antibacterialtreatment programtrial comparinguptakevolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The objective of this study is to assess the efficacy of antibiotic ointment prophylaxis to reduce incidence of corneal ulceration and subsequent blindness. We compare communities randomized to receive an intensive health promotion effort aimed at early prophylaxis for corneal abrasion to communities receiving standard-of care (no active intervention). Corneal ulceration is a leading cause of blindness globally, and once infection is present it is difficult to substantially improve visual potential of the eye. Individully randomized controlled trials have been unsuccessful at demonstrating large differences in clinical outcomes with different antimicrobial or adjunctive therapies. Prospective cohort studies have suggested that antibiotic prophylaxis
Is effective at reducing corneal ulceration, but a community randomized clinical trial is necessary to provide definitive evidence of the efficacy of interventions with antibiotic prophylaxis at the community level. We expect that this study will provide an evidence base for such an intervention through the following specific aims: 1) to determine if antibiotic prophylaxis
after corneal abrasion reduces the incidence of corneal ulceration in a community randomized trial. 2) To assess the costs and cost-effectiveness of a preventative intervention for microbial keratitis. 3) To determine the incidence of corneal ulceration and abrasion in this district of Taml Nadu, India. No community-randomized trial has ever been performed for microbial keratitis. These trials are difficult to conduct, because of infrastructure and logistical requirements as wel as ethical considerations. We address this by building on our collaborations between the University of California, San Francisco and the Aravind Eye Hospital in Madurai, India. Aravind has an existing infrastructure of community outreach and vision centers that will allow for this study to be completed at a large scale. Patients in control communities will receive treatment should they seek it, as it would be unethical not to provide treatment, but these communities will not receive active health promotion activities. If proven to be effective, this study will provide definitive evidence on a cost-effective, scalable intervention that could substantially reduce the burden of blindness particularly in rural communities in the developing world.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Risk factors for corneal abrasions in Nepal: a community-based study.
尼泊尔角膜擦伤的危险因素:一项基于社区的研究。
DOI:
10.1038/s41433-023-02809-0
发表时间:
2024
期刊:
Eye (London, England)
影响因子:
--
作者:
[Brekke,SylviaR, Giri,Puspa, Byanju,Raghunandan, Pradhan,Sangita, Bhandari,Gopal, Bhandari,Sadhan, Kandel,RamPrasad, Poudyal,Bimal, Gonzales,JohnA, Srinivasan,Muthiah, Upadhyay,Madan, Whitcher,JohnP, O'Brien,KieranS, Lietman,ThomasM, Ke]
通讯作者:
Ke
Smartphone-based Anterior Segment Imaging: A Comparative Diagnostic Accuracy Study of a Potential Tool for Blindness Prevalence Surveys.
基于智能手机的眼前段成像:失明患病率调查潜在工具的比较诊断准确性研究。
DOI:
10.1080/09286586.2021.1980589
发表时间:
2022-10
期刊:
Ophthalmic epidemiology
影响因子:
1.8
作者:
[Kumar A, Ali FS, Stevens VM, Melo JS, Venkatesh Prajna N, Lalitha P, Srinivasan M, Bhandari G, Bhandari S, Maamari RN, Fletcher DA, Lietman TM, Keenan JD]
通讯作者:
Keenan JD
DOI:
10.1016/j.ajo.2021.12.010
发表时间:
2022-05
期刊:
AMERICAN JOURNAL OF OPHTHALMOLOGY
影响因子:
4.2
作者:
[Srinivasan, Muthiah, Ravilla, Thulasiraj, Vijayakumar, Valaguru, Yesunesan, Devanesam, Mani, Iswarya, Whitcher, John P., Oldenburg, Catherine E., O'brien, Kieran S., Lietman, Thomas M., Keenan, Jeremy D.]
通讯作者:
Keenan, Jeremy D.
DOI:
10.1016/s2214-109x(21)00596-9
发表时间:
2022-04
期刊:
LANCET GLOBAL HEALTH
影响因子:
34.3
作者:
[O'Brien, Kieran S., Byanju, Raghunandan, Kandel, Ram P., Poudyal, Bimal, Gonzales, John A., Porco, Travis C., Whitcher, John P., Srinivasan, Muthiah, Upadhyay, Madan, Lietman, Thomas M., Keenan, Jeremy D.]
通讯作者:
Keenan, Jeremy D.
Risk factors for corneal ulcers: a population-based matched case-control study in Nepal.
角膜溃疡的危险因素:尼泊尔一项基于人群的匹配病例对照研究。
DOI:
10.1136/bjo-2022-322141
发表时间:
2023
期刊:
The British journal of ophthalmology
影响因子:
--
作者:
[Byanju,Raghunandan, Kandel,RamPrasad, Poudyal,Bimal, Bhandari,Sadhan, Ligal,Anju, Pradhan,Sangita, Gautam,Maria, Shrestha,Puspa, Sah,RanjeetKumar, Gonzales,JohnA, Porco,TravisC, Whitcher,JohnP, Srinivasan,Muthiah, Upadhyay,MadanPrasad, ]
通讯作者:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10439385
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10616840
-
项目类别:
-
资助金额:$7.34万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10397057
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
UCSF-Proctor Clinician Vision Scholars K12 Program
-
批准号:10610924
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
UCSF-Proctor Clinician Vision Scholars K12 Program
-
批准号:10409646
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10907941
-
项目类别:
-
资助金额:$2.6万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Azithromycin Reduction to Reach Elimination of Trachoma
-
批准号:10618166
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2020
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10397960
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10457913
-
项目类别:
-
资助金额:$79.62万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10222699
-
项目类别:
-
资助金额:$86.37万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10666415
-
项目类别:
-
资助金额:$74.59万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
-
批准号:10167111
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2019
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:9752569
-
项目类别:
-
资助金额:$60.55万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:10441068
-
项目类别:
-
资助金额:$84.29万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Kebele Elimination of Trachoma for Ocular Health
-
批准号:9965928
-
项目类别:
-
资助金额:$62.62万
-
财政年份:2017
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:9107191
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Digital Detection of Infectious Eye Epidemics
-
批准号:9030980
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Digital Detection of Infectious Eye Epidemics
-
批准号:9207459
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:10587368
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
Forecasting Trachoma Control
-
批准号:9267470
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2016
-
负责人:THOMAS M LIETMAN
-
依托单位:
海外基金